Do analysts rate COSM or HKPD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, COSM or HKPD?

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Cosmos Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cosmos Health $65.27M 0.41 -$19.15M -$0.64 N/A Hong Kong Pharma Digital Technology $13.43M 0.11 -$1.14M N/A N/A

Do analysts recommend MEDS or HKPD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, MEDS or HKPD?

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Wellgistics Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Wellgistics Health $23.34M 0.13 -$101.28M -$46.13 N/A Hong Kong Pharma Digital Technology $13.43M 0.11 -$1.14M N/A N/A

Is MEDS or HKPD more profitable?

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%. Company Net Margins Return on Equity Return on Assets Wellgistics Health -1,100.16% N/A -171.81% Hong Kong Pharma Digital Technology N/A N/A N/A

Do analysts recommend RDGT or HKPD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, RDGT or HKPD?

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Ridgetech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.02 -$1.25M N/A N/A Hong Kong Pharma Digital Technology $13.43M 0.11 -$1.14M N/A N/A

Is RDGT or HKPD more profitable?

Company Net Margins Return on Equity Return on Assets Ridgetech N/A N/A N/A Hong Kong Pharma Digital Technology N/A N/A N/A

Do analysts prefer HKPD or MCK?

McKesson has a consensus target price of $973.44, indicating a potential upside of 5.61%. Given McKesson's stronger consensus rating and higher possible upside, analysts plainly believe McKesson is more favorable than Hong Kong Pharma Digital Technology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 McKesson 0 Sell rating(s) 4 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.78

Which has better valuation & earnings, HKPD or MCK?

McKesson has higher revenue and earnings than Hong Kong Pharma Digital Technology. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hong Kong Pharma Digital Technology $13.43M 0.11 -$1.14M N/A N/A McKesson $403.43B 0.27 $4.76B $37.37 24.66

Do analysts prefer HKPD or COR?

Cencora has a consensus price target of $370.85, suggesting a potential upside of 10.12%. Given Cencora's stronger consensus rating and higher possible upside, analysts plainly believe Cencora is more favorable than Hong Kong Pharma Digital Technology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cencora 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.81

Which has better valuation & earnings, HKPD or COR?

Cencora has higher revenue and earnings than Hong Kong Pharma Digital Technology. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hong Kong Pharma Digital Technology $13.43M 0.11 -$1.14M N/A N/A Cencora $321.33B 0.20 $1.55B $13.46 25.02

Hong Kong Pharma Digital Technology (HKPD) Competitors

$0.14 -0.01 (-7.89%)

Closing price 09/3/2026 04:00 PM Eastern

Extended Trading

$0.14 0.00 (-1.43%)

As of 08:50 AM Eastern

Compare

HKPD vs. COSM, WGRX, RDGT, MCK, and COR

Should you buy Hong Kong Pharma Digital Technology stock or one of its competitors? Hong Kong Pharma Digital Technology's main competitors and comparable companies include Cosmos Health (COSM), Wellgistics Health (WGRX), Ridgetech (RDGT), McKesson (MCK), and Cencora (COR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare distributors" industry.

How does Hong Kong Pharma Digital Technology compare to Cosmos Health?

Cosmos Health (NASDAQ:COSM) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, profitability, risk and institutional ownership.

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Cosmos Health's net margin of -33.08%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cosmos Health	-33.08%	-56.88%	-18.03%
Hong Kong Pharma Digital Technology	N/A	N/A	N/A

12.6% of Cosmos Health shares are held by institutional investors. 26.2% of Cosmos Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Cosmos Health has a beta of 4.8, suggesting that its stock price is 380% more volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.23, suggesting that its stock price is 123% more volatile than the broader market.

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Cosmos Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cosmos Health	$65.27M	0.41	-$19.15M	-$0.64	N/A
Hong Kong Pharma Digital Technology	$13.43M	0.11	-$1.14M	N/A	N/A

In the previous week, Cosmos Health had 6 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 6 mentions for Cosmos Health and 0 mentions for Hong Kong Pharma Digital Technology. Cosmos Health's average media sentiment score of 0.73 beat Hong Kong Pharma Digital Technology's score of 0.00 indicating that Cosmos Health is being referred to more favorably in the media.

Company	Overall Sentiment
Cosmos Health	Positive
Hong Kong Pharma Digital Technology	Neutral

Summary

Cosmos Health beats Hong Kong Pharma Digital Technology on 7 of the 11 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Wellgistics Health?

Wellgistics Health (NASDAQ:MEDS) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%.

Company	Net Margins	Return on Equity	Return on Assets
Wellgistics Health	-1,100.16%	N/A	-171.81%
Hong Kong Pharma Digital Technology	N/A	N/A	N/A

Wellgistics Health has a beta of -1.77, indicating that its stock price is 277% less volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.23, indicating that its stock price is 123% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Wellgistics Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wellgistics Health	$23.34M	0.13	-$101.28M	-$46.13	N/A
Hong Kong Pharma Digital Technology	$13.43M	0.11	-$1.14M	N/A	N/A

In the previous week, Wellgistics Health's average media sentiment score of 0.00 equaled Hong Kong Pharma Digital Technology'saverage media sentiment score.

Company	Overall Sentiment
Wellgistics Health	Neutral
Hong Kong Pharma Digital Technology	Neutral

5.7% of Wellgistics Health shares are owned by institutional investors. 29.1% of Wellgistics Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Wellgistics Health and Hong Kong Pharma Digital Technology tied by winning 4 of the 8 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Ridgetech?

Ridgetech (NASDAQ:RDGT) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, media sentiment, risk and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Ridgetech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A
Hong Kong Pharma Digital Technology	$13.43M	0.11	-$1.14M	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
Hong Kong Pharma Digital Technology	N/A	N/A	N/A

45.3% of Ridgetech shares are held by institutional investors. 22.6% of Ridgetech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Ridgetech's average media sentiment score of 0.00 equaled Hong Kong Pharma Digital Technology'saverage media sentiment score.

Company	Overall Sentiment
Ridgetech	Neutral
Hong Kong Pharma Digital Technology	Neutral

Ridgetech has a beta of -0.08, indicating that its share price is 108% less volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.23, indicating that its share price is 123% more volatile than the broader market.

Summary

Ridgetech and Hong Kong Pharma Digital Technology tied by winning 3 of the 6 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to McKesson?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and McKesson (NYSE:MCK) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

85.1% of McKesson shares are owned by institutional investors. 0.1% of McKesson shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

McKesson has a net margin of 1.12% compared to Hong Kong Pharma Digital Technology's net margin of 0.00%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hong Kong Pharma Digital Technology	N/A	N/A	N/A
McKesson	1.12%	-253.21%	5.90%

Hong Kong Pharma Digital Technology has a beta of 2.23, indicating that its share price is 123% more volatile than the broader market. Comparatively, McKesson has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market.

McKesson has a consensus target price of $973.44, indicating a potential upside of 5.61%. Given McKesson's stronger consensus rating and higher possible upside, analysts plainly believe McKesson is more favorable than Hong Kong Pharma Digital Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78

McKesson has higher revenue and earnings than Hong Kong Pharma Digital Technology.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hong Kong Pharma Digital Technology	$13.43M	0.11	-$1.14M	N/A	N/A
McKesson	$403.43B	0.27	$4.76B	$37.37	24.66

In the previous week, McKesson had 33 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 33 mentions for McKesson and 0 mentions for Hong Kong Pharma Digital Technology. McKesson's average media sentiment score of 1.16 beat Hong Kong Pharma Digital Technology's score of 0.00 indicating that McKesson is being referred to more favorably in the news media.

Company	Overall Sentiment
Hong Kong Pharma Digital Technology	Neutral
McKesson	Positive

Summary

McKesson beats Hong Kong Pharma Digital Technology on 12 of the 14 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Cencora?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Cencora (NYSE:COR) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, valuation, dividends, earnings and analyst recommendations.

Cencora has a consensus price target of $370.85, suggesting a potential upside of 10.12%. Given Cencora's stronger consensus rating and higher possible upside, analysts plainly believe Cencora is more favorable than Hong Kong Pharma Digital Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cencora	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.81

Cencora has a net margin of 0.79% compared to Hong Kong Pharma Digital Technology's net margin of 0.00%. Cencora's return on equity of 125.45% beat Hong Kong Pharma Digital Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hong Kong Pharma Digital Technology	N/A	N/A	N/A
Cencora	0.79%	125.45%	4.18%

97.5% of Cencora shares are held by institutional investors. 0.4% of Cencora shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Cencora has higher revenue and earnings than Hong Kong Pharma Digital Technology.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hong Kong Pharma Digital Technology	$13.43M	0.11	-$1.14M	N/A	N/A
Cencora	$321.33B	0.20	$1.55B	$13.46	25.02

In the previous week, Cencora had 20 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 20 mentions for Cencora and 0 mentions for Hong Kong Pharma Digital Technology. Cencora's average media sentiment score of 1.37 beat Hong Kong Pharma Digital Technology's score of 0.00 indicating that Cencora is being referred to more favorably in the news media.

Company	Overall Sentiment
Hong Kong Pharma Digital Technology	Neutral
Cencora	Positive

Hong Kong Pharma Digital Technology has a beta of 2.23, suggesting that its stock price is 123% more volatile than the broader market. Comparatively, Cencora has a beta of 0.57, suggesting that its stock price is 43% less volatile than the broader market.

Summary

Cencora beats Hong Kong Pharma Digital Technology on 13 of the 14 factors compared between the two stocks.

Get Hong Kong Pharma Digital Technology News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HKPD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HKPD vs. The Competition

Export

Metric	Hong Kong Pharma Digital Technology	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.67M	$9.97B	$7.26B	$12.73B
Dividend Yield	N/A	2.56%	2.53%	8.56%
P/E Ratio	N/A	34.83	273.30	25.25
Price / Sales	0.11	4.88	621.31	98.12
Price / Cash	N/A	120.90	77.82	52.26
Price / Book	0.16	3.98	12.89	6.14
Net Income	-$1.14M	$310.54M	$3.47B	$349.01M
7 Day Performance	-59.68%	0.74%	0.52%	-0.31%
1 Month Performance	-66.66%	0.11%	5.63%	0.64%
1 Year Performance	-86.54%	15.75%	25.30%	14.83%

Hong Kong Pharma Digital Technology Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HKPD Hong Kong Pharma Digital Technology	0.6138 of 5 stars	$0.14 -7.9%	N/A	-87.5%	$1.67M	$13.43M	N/A	19	Gap Up
COSM Cosmos Health	1.4526 of 5 stars	$0.22 flat	N/A	-66.0%	$13.30M	$73.73M	N/A	100
WGRX Wellgistics Health	N/A	$3.46 -1.7%	N/A	N/A	$8.69M	$23.34M	N/A	31	High Trading Volume
RDGT Ridgetech	0.5734 of 5 stars	$0.81 flat	N/A	-99.5%	$2.94M	$132.16M	N/A	980	Gap Up
MCK McKesson	4.6553 of 5 stars	$862.27 +0.4%	$973.44 +12.9%	+33.6%	$100.53B	$403.43B	23.07	43,000	Positive News Ex-Dividend Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HKPD) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hong Kong Pharma Digital Technology (HKPD) Competitors

HKPD vs. COSM, WGRX, RDGT, MCK, and COR

How does Hong Kong Pharma Digital Technology compare to Cosmos Health?

Summary

How does Hong Kong Pharma Digital Technology compare to Wellgistics Health?

Summary

How does Hong Kong Pharma Digital Technology compare to Ridgetech?

Summary

How does Hong Kong Pharma Digital Technology compare to McKesson?

Summary

How does Hong Kong Pharma Digital Technology compare to Cencora?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HKPD vs. The Competition

Hong Kong Pharma Digital Technology Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hong Kong Pharma Digital Technology (HKPD) Competitors

HKPD vs. COSM, WGRX, RDGT, MCK, and COR

How does Hong Kong Pharma Digital Technology compare to Cosmos Health?

Is COSM or HKPD more profitable?

Do insiders and institutionals have more ownership in COSM or HKPD?

Do analysts rate COSM or HKPD?

Which has more volatility and risk, COSM or HKPD?

Which has higher earnings and valuation, COSM or HKPD?

Does the media refer more to COSM or HKPD?

Summary

How does Hong Kong Pharma Digital Technology compare to Wellgistics Health?

Is MEDS or HKPD more profitable?

Which has more volatility & risk, MEDS or HKPD?

Do analysts recommend MEDS or HKPD?

Which has better valuation & earnings, MEDS or HKPD?

Does the media refer more to MEDS or HKPD?

Do institutionals and insiders have more ownership in MEDS or HKPD?

Summary

How does Hong Kong Pharma Digital Technology compare to Ridgetech?

Do analysts recommend RDGT or HKPD?

Which has preferable valuation & earnings, RDGT or HKPD?

Is RDGT or HKPD more profitable?

Do institutionals & insiders believe in RDGT or HKPD?

Does the media refer more to RDGT or HKPD?

Which has more volatility and risk, RDGT or HKPD?

Summary

How does Hong Kong Pharma Digital Technology compare to McKesson?

Do institutionals and insiders believe in HKPD or MCK?

Is HKPD or MCK more profitable?

Which has more risk and volatility, HKPD or MCK?

Do analysts prefer HKPD or MCK?

Which has better valuation & earnings, HKPD or MCK?

Does the media prefer HKPD or MCK?

Summary

How does Hong Kong Pharma Digital Technology compare to Cencora?

Do analysts prefer HKPD or COR?

Is HKPD or COR more profitable?

Do insiders & institutionals have more ownership in HKPD or COR?

Which has better valuation & earnings, HKPD or COR?

Does the media prefer HKPD or COR?

Which has more risk and volatility, HKPD or COR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HKPD vs. The Competition

Hong Kong Pharma Digital Technology Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools